Evidence map›Paper›PMID 38287249›Full record

ArticleBMC gastroenterology2024

Clinical factors associated with stable treatment of chronic constipation in Japanese patients.

Kazuki Ishibashi, Yuji Urabe, Nhu Thi Hanh Vu, Shunsuke Miyauchi, Takeo Nakamura, Hirona Konishi, Junichi Mizuno, Motomitsu Fukuhara, Hidehiko Takigawa, Ryo Yuge and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Kazuki IshibashiDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Yuji UrabeDepartment of Gastrointestinal Endoscopy and Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Nhu Thi Hanh VuDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Shunsuke MiyauchiHealth Service Center, Hiroshima University, 1-7-1 Kagamiyama, 739-8514, Higashihiroshima, Japan.
Takeo NakamuraDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Hirona KonishiDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Junichi MizunoDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Motomitsu FukuharaDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Hidehiko TakigawaDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Ryo YugeDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Duc Trong QuachDepartment of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Vietnam.
Shiro OkaDepartment of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Toru HiyamaHealth Service Center, Hiroshima University, 1-7-1 Kagamiyama, 739-8514, Higashihiroshima, Japan. tohiyama@hiroshima-u.ac.jp.
Hiroshima University · JPHiroshima University Hospital · JPUniversity of Medicine and Pharmacy at Ho Chi Minh City · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsChronic constipation (CC) is one of the most common gastrointestinal disorders in the general population. Although there are many treatment options, achieving a stable treatment for CC remains one of the challenges in clinical practice. This study aimed to evaluate the clinical factors associated with stable treatment for CC in Japanese patients.

methodsA retrospective, cross-sectional, and multicenter study was carried out. Patients were eligible for inclusion if they fulfilled the Rome IV criteria for diagnosing CC and had been treated for at least one and a half years. Patients with up to two prescription modifications for CC in one year were defined as the stable treatment group, whereas those with three or more prescription changes were defined as the unstable treatment group. Univariate and multivariate analyses were carried out to identify factors associated with CC.

resultsA total of 114 patients have been recruited. There were 82 patients (77.0%) in the stable treatment group and 32 patients (23.0%) in the unstable treatment group. Based on multivariate likelihood analysis, only using acid-suppressive drugs contributed to stability treatment in CC patients (odds ratio: 2.81, 95% confidence interval: 1.12-7.08, p = 0.03).

conclusionAdministration of acid-suppressive drugs was the only factor related to the stability of CC treatment. Further studies are needed to validate the results as well as clarify the causes.

Indexed as

ConstipationGastrointestinal DiseasesCross-Sectional StudiesHumansJapanRetrospective StudiesAcid-suppressive drugsChronic constipationClinical factorStable treatmentUnstable treatment

Identifiers

PMID38287249
PMCPMC10823644
OpenAlexW4391316201

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.